SBA SBIR Commercialization Benchmarks for Repeat Awardees

Repeat awardees under the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs face a fundamental shift in eligibility criteria. Under a policy notice published in the Federal Register, the Small Business Administration (SBA) has established strict commercialization benchmarks that tie continued grant access directly to non-grant revenue generation. For sales teams operating inside high-volume research and development contractors, non-SBIR sales are no longer just a milestone on a commercialization report. They represent the barrier between ongoing eligibility and an agency-wide proposal ban.

Understanding these benchmarks, the revenue streams that fulfill them, and how sales pipelines must adapt determines whether repeat awardees can preserve access to federal innovation seed capital.

The SBA Commercialization Benchmarks Explained

Historically, the SBIR program has evaluated past performance through commercialization rate benchmarks designed to confirm that awardees turn research into market applications. According to the official performance benchmarks on SBIR.gov, standard rules assess progress through Phase I to Phase II transition ratios or dollar thresholds of commercial activity per Phase II contract.

However, the SBA introduced higher operational hurdles specifically directed at repeat winners. As detailed in the Federal Register notice on updated minimum performance standards, the SBA established new requirements targeting Small Business Concerns (SBCs) that have received more than 25 Phase II awards across all federal agencies during the five most recently completed fiscal years, excluding the current fiscal year.

This notice outlines a clear progression for repeat awardees:

• Assessment threshold for Fiscal Year 2027: The affected business must derive at least 33 percent of its total company revenue from non-SBIR sources across the three most recent fiscal years, excluding the current fiscal year.
• Assessment threshold for Fiscal Year 2028 and beyond: The required non-SBIR revenue share rises to at least 50 percent across the three most recent fiscal years, excluding the current fiscal year.
• The consequence of non-compliance: An SBC that fails to meet the threshold is barred from submitting proposals for any new Phase I or Direct-to-Phase II award across all participating federal agencies for a one-year period beginning on the determination date.
• Implementation timeline: The standards take effect November 15, 2026, with public comments open through October 31, 2026, as published in the Federal Register notice.

For companies below the 25-award threshold, these specific percentage benchmarks do not apply. But for dedicated federal research shops that cross that volume, grant dependence triggers an administrative disqualification.

What Counts as Non-SBIR Revenue

To structure a sales strategy that keeps the firm eligible, sales and capture teams must understand the mathematical formula applied by the SBA.

The denominator of the benchmark calculation is the company's total revenue from all sources across the three relevant fiscal years. The numerator consists exclusively of non-SBIR revenue. Under the provisions defined in the Federal Register commercialization benchmark notice, non-SBIR revenue includes:

1. Private commercial sales: Revenue generated from private-sector customers, commercial software licenses, industrial consulting, hardware deliveries, and enterprise subscriptions.
2. Phase III SBIR/STTR awards: Work authorized under Phase III of the SBIR and STTR programs (15 U.S.C. 638(r)). Phase III contracts derive from prior SBIR work but must be funded by non-SBIR federal dollars, private contracts, or commercial procurement lines.
3. Other non-SBIR government contracts: Standard Federal Acquisition Regulation (FAR) procurements, Broad Agency Announcements funded through base agency budgets, defense production orders, and other non-SBIR public awards.

Critically, Phase I and Phase II grant funding from any participating agency is excluded from the numerator.

The Mathematical Threshold in Practice

The Federal Register details an illustrative calculation that demonstrates the margin between compliance and a one-year proposal exclusion:

In this scenario, total non-SBIR revenue stands at $1,200,000 against $4,000,000 in total revenue. That yields an exact non-SBIR share of 30 percent. Under the 33 percent requirement slated for the Fiscal Year 2027 assessment, the business fails the benchmark and faces a full one-year suspension from new Phase I and Direct-to-Phase II solicitations. Under the 50 percent requirement taking effect in Fiscal Year 2028, the shortfall becomes even steeper.

Sales Strategies for Repeat Awardees

For business development and sales teams at advanced technical firms, navigating this policy environment requires a deliberate realignment of pipeline priorities. Moving from 30 percent commercial capture to 33 percent or 50 percent non-grant revenue requires structural changes across three fronts.

Accelerating Phase III Transition Pathways

Phase III contracting represents the most natural bridge for SBIR contractors. Because Phase III awards carry sole-source justification rights derived from earlier Phase I and II work, government procurement officers can award Phase III contracts without entering full and open competition.

Sales teams should systematically audit completed Phase II deliverables and target agency program executive offices (PEOs) that have operational funding. Securing production, integration, or sustainment contracts funded through standard program dollars satisfies the non-SBIR revenue requirement without demanding an immediate pivot to enterprise commercial markets.

Structuring Private-Sector Licensing and Dual-Use Deals

Federal research programs frequently yield dual-use capabilities applicable to enterprise logistics, advanced materials, cybersecurity, or industrial robotics. To generate qualified non-SBIR revenue, sales teams must move from pure technical milestone delivery to productized offerings.

Commercial license agreements, paid proof-of-concept engagements with corporate partners, and direct equipment sales provide immediate numerator growth. Exploring corporate joint ventures or strategic corporate development paths can help balance high research expenditures with predictable private revenue.

Pipeline Forecasting and Revenue Mix Governance

Because the benchmark relies on a rolling three-year calculation, an influx of Phase II grant money without corresponding commercial or Phase III sales can inadvertently push a firm out of compliance. Sales leaders must work in lockstep with financial controllers to forecast the impact of major grant wins on the overall revenue ratio.

Before booking an additional Phase II grant near the end of a fiscal cycle, the revenue team should model whether the non-SBIR pipeline can deliver the required 33 percent or 50 percent margin across the lookback period. Contractors navigating these financial balancing acts can review the Knowledge guides for finance to model sustainable capital structures alongside public procurement.

Next Steps for Commercial Capture

Teams managing deep-tech research portfolios must treat the SBA's benchmark framework as an operational constraint on pipeline planning. Ensuring continued eligibility requires proactive internal coordination:

• Audit Phase II award counts across all agencies for the past five completed fiscal years to verify whether the 25-award threshold applies.
• Segment current accounting ledgers to clearly distinguish Phase I and Phase II awards from Phase III contracts and non-SBIR agency procurements.
• Model multi-year revenue projections against the 33 percent Fiscal Year 2027 and 50 percent Fiscal Year 2028 requirements.
• Focus near-term capture efforts on sole-source Phase III conversions and private enterprise contracts to lift the numerator before eligibility windows close.

Balancing federal innovation programs with rigorous private commercialization ensures that firms maintain both their technical edge and their regulatory standing. Repeat awardees planning sustainable expansion can evaluate commercial trajectory modeling with Fund Your Growth by Ember to keep revenue splits aligned with evolving institutional benchmarks.